6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-28), Senti Biosciences's 6-1 Month Momentum % is -22.06%.
The industry rank for Senti Biosciences's 6-1 Month Momentum % or its related term are showing as below:
SNTI's 6-1 Month Momentum % is ranked worse than 67.23% of 1526
companies
in the Biotechnology industry
Industry Median: -5.24
vs SNTI: -22.06
Competitive Comparison of Senti Biosciences's 6-1 Month Momentum %
For the Biotechnology subindustry, Senti Biosciences's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senti Biosciences's 6-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Senti Biosciences's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Senti Biosciences's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Senti Biosciences 6-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Senti Biosciences's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Senti Biosciences (Senti Biosciences) Business Description
Senti Biosciences Inc is a preclinical biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SNTI has been successfully added to your